Common Stock, Shares, Issued of Intellipharmaceutics International Inc. from 30 Nov 2010 to 23 Feb 2028

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Intellipharmaceutics International Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 30 Nov 2010 to 23 Feb 2028.
  • Intellipharmaceutics International Inc. Common Stock, Shares, Issued for the quarter ending 23 Feb 2028 was 33,092,665.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Intellipharmaceutics International Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2028 33,092,665 23 Feb 2028 6-K 26 Sep 2023 2023 Q1
Q3 2023 33,092,665 0 0% 31 Aug 2023 6-K 16 Oct 2023 2023 Q3
Q2 2023 33,092,665 0 0% 31 May 2023 6-K 26 Sep 2023 2023 Q2
Q4 2022 33,092,665 0 0% 30 Nov 2022 20-F/A 06 Feb 2024 2023 FY
Q3 2022 33,092,665 +30,317,434 +1092% 31 Aug 2022 6-K 14 Oct 2022 2022 Q3
Q2 2022 33,092,665 0 0% 31 May 2022 6-K 26 Sep 2023 2023 Q2
Q1 2022 33,092,665 +9,414,560 +40% 28 Feb 2022 6-K 14 Apr 2022 2022 Q1
Q4 2021 33,092,665 +9,414,560 +40% 30 Nov 2021 6-K 14 Oct 2022 2022 Q3
Q3 2021 2,775,231 -20,902,874 -88% 31 Aug 2021 20-F/A 09 May 2022 2021 FY
Q2 2021 33,092,665 +9,414,560 +40% 31 May 2021 6-K 15 Jul 2021 2021 Q2
Q1 2021 23,678,105 0 0% 28 Feb 2021 6-K 14 Apr 2022 2022 Q1
Q4 2020 23,678,105 +1,592,249 +7.2% 30 Nov 2020 20-F/A 06 Feb 2024 2023 FY
Q3 2020 23,678,105 +1,592,249 +7.2% 31 Aug 2020 6-K 15 Oct 2020 2020 Q3
Q2 2020 23,678,105 +1,602,528 +7.3% 31 May 2020 6-K 15 Jul 2020 2020 Q2
Q1 2020 23,678,105 +1,752,528 +8% 29 Feb 2020 6-K 29 May 2020 2020 Q1
Q4 2019 22,085,856 +3,833,613 +21% 30 Nov 2019 20-F 31 Mar 2021 2020 FY
Q3 2019 22,085,856 +17,732,178 +407% 31 Aug 2019 6-K 11 Oct 2019 2019 Q3
Q2 2019 22,075,577 -21,462,273 -49% 31 May 2019 6-K 10 Jul 2019 2019 Q2
Q1 2019 21,925,577 28 Feb 2019 6-K 15 Apr 2019 2019 Q1
Q4 2018 18,252,243 +14,781,792 +426% 30 Nov 2018 20-F 31 Mar 2021 2020 FY
Q3 2018 4,353,678 31 Aug 2018 6-K 15 Oct 2018 2018 Q3
Q2 2018 43,537,850 +12,994,687 +43% 31 May 2018 6-K 24 Jul 2018 2018 Q2
Q4 2017 3,470,451 -26,319,541 -88% 30 Nov 2017 20-F 30 Mar 2020 2019 FY
Q2 2017 30,543,163 31 May 2017 6-K 11 Jul 2017 2017 Q2
Q1 2017 30,155,837 28 Feb 2017 6-K 12 Apr 2017 2016 Q1
Q4 2016 29,789,992 +5,545,942 +23% 30 Nov 2016 20-F 04 Mar 2019 2018 FY
Q4 2015 24,244,050 +787,439 +3.4% 30 Nov 2015 20-F 01 Mar 2018 2017 FY
Q4 2014 23,456,611 +2,026,000 +9.5% 30 Nov 2014 20-F 28 Feb 2017 2016 FY
Q1 2014 22,819,711 28 Feb 2014 6-K 14 Apr 2014 2014 Q1
Q4 2013 21,430,611 +3,523,674 +20% 30 Nov 2013 20-F 21 Mar 2016 2015 FY
Q4 2012 17,906,937 +1,998,493 +13% 30 Nov 2012 20-F 18 Feb 2014 2013 FY
Q4 2011 15,908,444 +5,001,390 +46% 30 Nov 2011 20-F/A 01 Feb 2013 2012 FY
Q4 2010 10,907,054 30 Nov 2010 20-F 11 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.